Blog
Equifax Expands in Mexico With $750 Million Círculo de Crédito Deal
Key Points
- Interested in Equifax, Inc.? Here are five stocks we like better.
- Equifax has agreed to buy Mexico’s Círculo de Crédito for an enterprise value of $750 million, marking a major
3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
Key Points
- Interested in VanEck Rare Earth and Strategic Metals ETF? Here are five stocks we like better.
- China's rare-earth dominance stems from decades of investment in refining and processing
Dycom Industries Says Fiber, Data Center Demand Gives Backlog ‘Staying Power’
Key Points
- Interested in Dycom Industries, Inc.? Here are five stocks we like better.
- Dycom sees lasting demand from fiber, long-haul networks and data center projects, with CEO Dan Peyovich
Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
Key Points
- Interested in Microsoft Corporation? Here are five stocks we like better.
- Microsoft is routing some Excel and Outlook prompts to its own MAI models instead of OpenAI or Anthropic to
Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
Key Points
- Interested in Delta Air Lines, Inc.? Here are five stocks we like better.
- Delta Air Lines reported strong Q2 2026 results with revenue up 30.3% and raised guidance, prompting 27
Why "Big Short" Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks
Key Points
- Interested in Flutter Entertainment PLC? Here are five stocks we like better.
- Michael Burry recently bought shares of DraftKings and Flutter Entertainment, betting on a recovery in
Capri Charts Post-Versace Comeback With Michael Kors Revamp, Jimmy Choo Growth
Key Points
- Interested in Capri Holdings Limited? Here are five stocks we like better.
- Capri is refocusing after selling Versace, with management now concentrating on Michael Kors and Jimmy
Clarivate to Sell Life Sciences Unit to Altaris for $600M, Refocus Core Business
Key Points
- Interested in Clarivate PLC? Here are five stocks we like better.
- Clarivate will sell substantially all of its Life Sciences & Healthcare segment to Altaris for $600 million, with
Chewy Annual Meeting: Directors Elected, Deloitte Ratified and Pay Vote Approved
Key Points
- Interested in Chewy? Here are five stocks we like better.
- At Chewy’s 2026 Annual Meeting, shareholders elected all five Class I director nominees to three-year terms ending at the
AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage
Key Points
- Interested in Astrazeneca Plc? Here are five stocks we like better.
- AstraZeneca updated its 2030 sustainability targets, lowering its Scope 3 emissions goal to a 35% reduction from
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
Key Points
- Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better.
- Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash
Veritone Shareholders Back Share Increase, CEO Awards as Debt Questions Loom
Key Points
- Interested in Veritone, Inc.? Here are five stocks we like better.
- Veritone shareholders approved all six proposals at the 2026 annual meeting, including re-electing two directors
Veritone Maps AI Growth Push as Oracle Partnership Targets Cost Savings
Key Points
- Interested in Veritone, Inc.? Here are five stocks we like better.
- Veritone outlined a broad AI strategy centered on turning unstructured data like video, audio and documents into
Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgA Nephropathy, Sets Launch
Key Points
- Interested in Vera Therapeutics, Inc.? Here are five stocks we like better.
- Vera Therapeutics won accelerated FDA approval for TRUTAKNA (atacicept-vymj) to treat adults with primary
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Key Points
- Interested in Turn Therapeutics Inc.? Here are five stocks we like better.
- Turn Therapeutics refined the stage two design of its GX-03 phase II eczema trial after an interim
TruBridge Stockholders Approve IKS Merger at Special Meeting
Key Points
- Interested in TruBridge, Inc.? Here are five stocks we like better.
- TruBridge stockholders approved the company’s merger agreement with Inventurus Knowledge Solutions Inc. (IKS)
Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
Key Points
- Interested in Starbucks Corporation? Here are five stocks we like better.
- Starbucks is building internal AI tools to replace Microsoft and IBM software, targeting cuts to its $400
Tarsus Pharmaceuticals Enters Retina Market With iRenix Deal, Adds IRX-101 to Pipeline
Key Points
- Interested in Tarsus Pharmaceuticals, Inc.? Here are five stocks we like better.
- Tarsus Pharmaceuticals closed its acquisition of iRenix Medical, adding IRX-101 to its pipeline and
Power Struggle: Wolfspeed Sues Navitas Over AI Chips
Key Points
- Interested in Navitas Semiconductor Corporation? Here are five stocks we like better.
- Wolfspeed sued Navitas Semiconductor in Delaware federal court, alleging its GaN and SiC chip
Solstice Advanced Mat Bets on AI Demand With $14.5B Element Solutions Deal
Key Points
- Interested in Solstice Advanced Mat? Here are five stocks we like better.
- Solstice Advanced Materials agreed to buy Element Solutions in a cash-and-stock deal valued at about $14.5
Why WD-40 Is Proving Great Businesses Never Go Out of Style
Key Points
- Interested in WD-40 Company? Here are five stocks we like better.
- WD-40 Company reported robust fiscal Q3 results, with revenue rising 24% and net income growing 44%, driven by
Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Key Points
- Interested in Super Micro Computer, Inc.? Here are five stocks we like better.
- Super Micro Computer launched a turnkey Kubernetes Edge AI appliance with Red Hat OpenShift and Portworx
MarketBeat Week in Review – 07/06 - 07/10
Key Points
- Interested in SpaceX? Here are five stocks we like better.
- Corporate earnings season is set to ramp up next week, with results expected to top last quarter's already strong performance
SBC Medical Group Shareholders Approve Board, Charter Changes at Annual Meeting
Key Points
- Interested in SBC Medical Group Holdings Incorporated? Here are five stocks we like better.
- SBC Medical Group held its 2026 annual meeting virtually and established a quorum, with
Rackspace Technology Cuts 2026 Outlook as $250M Stock Sale Fuels AI Push
Key Points
- Interested in Rackspace Technology, Inc.? Here are five stocks we like better.
- Rackspace is doubling down on enterprise AI infrastructure, launching a $250 million at-the-market